Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Press Releases

KalVista Pharmaceuticals to Showcase Data at 2024 ACAAI Annual Scientific Meeting

  • The Pharma Data
  • October 19, 2024

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced that five of its abstracts have been accepted for e-Poster presentations at the 2024 Annual Scientific Meeting of the American College of Allergy,…

Read MoreKalVista Pharmaceuticals to Showcase Data at 2024 ACAAI Annual Scientific Meeting
  • Press Releases

Nordic Group BV Expands U.S. Launch of LACRIFILL® Gel for Dry Eye Treatment

  • The Pharma Data
  • October 19, 2024

Nordic Pharma, a subsidiary of Nordic Group BV, is advancing the U.S. introduction of LACRIFILL® Canalicular Gel, a novel therapy for dry eye, during the 2024 American Academy of Ophthalmology…

Read MoreNordic Group BV Expands U.S. Launch of LACRIFILL® Gel for Dry Eye Treatment
  • Research

Celltrion Highlights Two-Year Analysis Supporting Dose Escalation for CT-P13 SC in IBD

  • The Pharma Data
  • October 19, 2024

Celltrion has announced two-year findings from a post-hoc analysis of the LIBERTY studies (LIBERTY-CD and LIBERTY-UC), presented at United European Gastroenterology (UEG) Week 2024 in Vienna. The analysis shows that…

Read MoreCelltrion Highlights Two-Year Analysis Supporting Dose Escalation for CT-P13 SC in IBD
  • Research

Merck’s Clesrovimab Significantly Reduces RSV Incidence and Hospitalizations in Infants

  • The Pharma Data
  • October 19, 2024

Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has shared positive results from its Phase 2b/3 clinical trial (MK-1654-004) evaluating clesrovimab, an investigational monoclonal antibody designed to…

Read MoreMerck’s Clesrovimab Significantly Reduces RSV Incidence and Hospitalizations in Infants
  • Research

Medidata Launches Rave Lite to Accelerate Early and Late-Stage Clinical Trial Growth

  • The Pharma Data
  • October 19, 2024

Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has launched Medidata Rave Lite, an extension of its flagship clinical research software,…

Read MoreMedidata Launches Rave Lite to Accelerate Early and Late-Stage Clinical Trial Growth
  • Press Releases

Xaira Therapeutics Names Dr. Debbie Law as Chief Scientific Officer and Julia Tran as Chief People Officer

  • The Pharma Data
  • October 18, 2024

Xaira Therapeutics Appoints Dr. Debbie Law as Chief Scientific Officer and Julia Tran as Chief People Officer Xaira Therapeutics, an integrated biotechnology firm focused on leveraging AI to transform drug…

Read MoreXaira Therapeutics Names Dr. Debbie Law as Chief Scientific Officer and Julia Tran as Chief People Officer
  • Business

SullivanCotter: Rising Healthcare Executive Pay Reflects Competitive Talent Market

  • The Pharma Data
  • October 18, 2024

SullivanCotter Reports on Rising Healthcare Executive Compensation Amid Talent Competition SullivanCotter, a leading consulting firm specializing in total rewards programs and workforce solutions for healthcare, has published its 2024 Health…

Read MoreSullivanCotter: Rising Healthcare Executive Pay Reflects Competitive Talent Market
  • Press Releases

Alnylam Files Application for Vutrisiran to Treat ATTR Amyloidosis

  • The Pharma Data
  • October 18, 2024

Alnylam Pharmaceuticals, Inc. has submitted a Type II variation application to the European Medicines Agency (EMA) for vutrisiran, an investigational RNA interference (RNAi) therapy aimed at treating ATTR amyloidosis with…

Read MoreAlnylam Files Application for Vutrisiran to Treat ATTR Amyloidosis
  • Business

2024 Personalized Nutrition Market Report: Types, Forms, Applications, and End-Use Markets

  • The Pharma Data
  • October 18, 2024

Personalized Nutrition Market Report 2024: Overview and Growth Projections The report titled “Personalized Nutrition Market – Types, Forms, Applications and End-Use Markets” has been released by ResearchAndMarkets.com. The global personalized…

Read More2024 Personalized Nutrition Market Report: Types, Forms, Applications, and End-Use Markets
  • Business

Wolters Kluwer AI Labs Celebrates First Year of Collaboration on Responsible AI Features for UpToDate

  • The Pharma Data
  • October 18, 2024

Wolters Kluwer Health is celebrating the first anniversary of AI Labs for UpToDate® with the introduction of advanced AI capabilities aimed at enhancing clinical decision-making. This experimental initiative places health…

Read MoreWolters Kluwer AI Labs Celebrates First Year of Collaboration on Responsible AI Features for UpToDate
  • Business

ByHeart Expands Retail Presence by 200% with Launch in Walmart, Whole Foods, and Wegmans

  • The Pharma Data
  • October 18, 2024

ByHeart Expands Distribution to Walmart, Whole Foods, and Wegmans, Boosting Retail Presence by Over 200% ByHeart, the evidence-backed infant nutrition company, has announced its expansion into Walmart, Whole Foods Market,…

Read MoreByHeart Expands Retail Presence by 200% with Launch in Walmart, Whole Foods, and Wegmans
  • Business

Upfront Joins athenahealth Marketplace to Boost Revenue for Healthcare Enterprises

  • The Pharma Data
  • October 18, 2024

Upfront Partners with athenahealth to Enhance Patient Engagement and Revenue Growth for Healthcare Providers Upfront Healthcare, a leading patient engagement technology company, has announced its partnership with athenahealth Inc. through…

Read MoreUpfront Joins athenahealth Marketplace to Boost Revenue for Healthcare Enterprises
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Acadia Pharmaceuticals Announces Year-End Retirement of R&D Head Elizabeth H.Z. Thompson, Ph.D.
  • Contineum Therapeutics Announces Encouraging Topline Results from Exploratory Phase 1b Study of PIPE-791 in Chronic Pain
  • Corcept’s Phase 2 Trial of Dazucorilant Shows Two-Year Survival Advantage in Amyotrophic Lateral Sclerosis Patients
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.